Gene · 4734
Papers3,453
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,453
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Abnormal Fetal Lung of Hoxa1-/- Piglets Is Rescued by Maternal Feeding with All-Trans Retinoic Acid. | Animals (Basel) | 2023 | 37760250 | PubTator, text mining | PubMed |
| Regulation of Phosphoinositide Signaling by Scaffolds at Cytoplasmic Membranes. | Biomolecules | 2023 | 37759697 | PubTator, text mining | PubMed |
| Intercellular adhesion molecule 2 as a novel prospective tumor suppressor induced by ERG promotes ubiquitination-mediated radixin degradation to inhibit gastric cancer tumorigenicity and metastasis. | J Transl Med | 2023 | 37759298 | PubTator, text mining | PubMed |
| Analysis of asymptomatic Drosophila models for ALS and SMA reveals convergent impact on functional protein complexes linked to neuro-muscular degeneration. | BMC Genomics | 2023 | 37759179 | PubTator, text mining | PubMed |
| Spotlights on ubiquitin-specific protease 12 (USP12) in diseases: from multifaceted roles to pathophysiological mechanisms. | J Transl Med | 2023 | 37752518 | PubTator, text mining | PubMed |
| Discovery of Nedd4 auto-ubiquitination inhibitors. | Sci Rep | 2023 | 37749144 | PubTator, text mining | PubMed |
| INHAT subunit SET/TAF-Iβ regulates PRC1-independent H2AK119 mono-ubiquitination via E3 ligase MIB1 in colon cancer. | NAR Cancer | 2023 | 37746636 | PubTator, text mining | PubMed |
| Regenerating gene 4 promotes chemoresistance of colorectal cancer by affecting lipid droplet synthesis and assembly. | World J Gastroenterol | 2023 | 37744296 | PubTator, text mining | PubMed |
| Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway. | Cancer Cell Int | 2023 | 37743467 | PubTator, text mining | PubMed |
| FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA. | J Transl Med | 2023 | 37737187 | PubTator, text mining | PubMed |
| Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability. | Nat Struct Mol Biol | 2023 | 37735617 | PubTator, text mining | PubMed |
| Cardiac microRNAs: diagnostic and therapeutic potential. | Arch Med Sci | 2023 | 37732050 | PubTator, text mining | PubMed |
| Identification, characterization and expression profiles of E2 and E3 gene superfamilies during the development of tetrasporophytes in Gracilariopsis lemaneiformis (Rhodophyta). | BMC Genomics | 2023 | 37723489 | PubTator, text mining | PubMed |
| Protein ISGylation: a posttranslational modification with implications for malignant neoplasms. | Explor Target Antitumor Ther | 2023 | 37711589 | PubTator, text mining | PubMed |
| Function and mechanism of MCM8 in the development and progression of colorectal cancer. | J Transl Med | 2023 | 37710286 | PubTator, text mining | PubMed |
| Knockout of c-Cbl/Cbl-b slows c-Met trafficking resulting in enhanced signaling in corneal epithelial cells. | J Biol Chem | 2023 | 37690689 | PubTator, text mining | PubMed |
| Estrogens and Estrogen Receptor Modulators in Cancer Research and Therapy. | Cancers (Basel) | 2023 | 37686595 | PubTator, text mining | PubMed |
| Histone 4 lysine 20 tri-methylation: a key epigenetic regulator in chromatin structure and disease. | Front Genet | 2023 | 37671044 | PubTator, text mining | PubMed |
| Extracellular vesicles in gastric cancer: role of exosomal lncRNA and microRNA as diagnostic and therapeutic targets. | Front Physiol | 2023 | 37664422 | PubTator, text mining | PubMed |
| Tumor cell-derived exosomes regulate macrophage polarization: Emerging directions in the study of tumor genesis and development. | Heliyon | 2023 | 37662730 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4734/papers?page=16